Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan-Hydrochlorothiazide in Hypertension (Chinese Population)
NCT00847834Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2003
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of irbesartan + hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Sanofi. Primary endpoint: Proportion of patients who reach a diastolic blood pressure <85 mmHg at 8 weeks. Started Dec 2003; status: completed.
02
Drugs
irbesartan + hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00847834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847834.